Q4 2018 Holdings
Filed 2019-02-13 | 54 holdings | $184.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celgene Corp | RIGHT 12/31/2030 | 151020112 | $3 | 6,000 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $10 | 1,020 | 0.0% |
| Mylan N V | CALL | N59465909 | $36 | 1,586 | 0.0% |
| Aptargroup Inc(ATR) | COM | 038336103 | $103 | 1,090 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $106 | 475 | 0.0% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $108 | 1,590 | 0.0% |
| Conformis Inc(CFMS)A | COM | 20717E101 | $49.0K | 136,851 | 0.0% |
| Epizyme Inc(EPZMEUR)A | COM | 29428V104 | $156.8K | 25,449 | 0.1% |
| Aquinox Pharmaceuticals IncA | COM | 03842B101 | $159.2K | 73,717 | 0.1% |
| Opiant Pharmaceuticals IncA | COM | 683750103 | $200.9K | 13,901 | 0.1% |
| TG Therapeutics Inc(TGTX)A | COM | 88322Q108 | $266.5K | 65,000 | 0.1% |
| Seaspine Hldgs Corp(SPNEUSD)A | COM | 81255T108 | $282.0K | 15,459 | 0.2% |
| Invacare CorpA | COM | 461203101 | $317.8K | 73,902 | 0.2% |
| Cymabay Therapeutics Inc(CBAYUSD)A | COM | 23257D103 | $370.6K | 47,096 | 0.2% |
| Fluidigm Corp del(LAB)A | COM | 34385P108 | $434.9K | 50,455 | 0.2% |
| Dicerna Pharmaceuticals Inc(DRNAUSD)A | COM | 253031108 | $439.1K | 41,074 | 0.2% |
| Albireo Pharma Inc(BDQM)A | COM | 01345P106 | $442.3K | 18,029 | 0.2% |
| Centene Corp del(CNC)A | COM | 15135B101 | $495.8K | 4,300 | 0.3% |
| Natera Inc(NTRA)A | COM | 632307104 | $552.0K | 39,539 | 0.3% |
| Amicus Therapeutics Inc(FOLD)A | COM | 03152W109 | $601.1K | 62,750 | 0.3% |
| Anthem Inc(ELV)A | COM | 036752103 | $604.0K | 2,300 | 0.3% |
| Sage Therapeutics Inc(SG7)A | COM | 78667J108 | $792.3K | 8,271 | 0.4% |
| Puma Biotechnology Inc(PBYI)A | COM | 74587V107 | $860.8K | 42,301 | 0.5% |
| Arqule Inc(ARQLUSD)A | COM | 04269E107 | $954.6K | 344,618 | 0.5% |
| Tricida Inc(1T7)A | COM | 89610F101 | $955.5K | 40,522 | 0.5% |
| Ascendis Pharma A S(ASND)A | SPONSORED ADR | 04351P101 | $955.7K | 15,254 | 0.5% |
| Caretrust REIT Inc(CTRE)A | COM | 14174T107 | $956.2K | 51,264 | 0.5% |
| Affimed N VA | COM | N01045108 | $1.0M | 335,774 | 0.6% |
| Foamix Pharmaceuticals LTDA | SHS | M46135105 | $1.1M | 294,660 | 0.6% |
| Array Biopharma Inc(ARRYEUR)A | COM | 04269X105 | $1.3M | 90,412 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE)A | COM | 98420N105 | $1.3M | 205,104 | 0.7% |
| Biocryst Pharmaceuticals(BCRX)A | COM | 09058V103 | $1.3M | 163,959 | 0.7% |
| Biospecifics Technologies Co(BSTC)A | COM | 090931106 | $1.3M | 22,000 | 0.7% |
| Loxo Oncology IncA | COM | 548862101 | $1.4M | 10,000 | 0.8% |
| Apellis Pharmaceuticals Inc(APLS)A | COM | 03753U106 | $1.4M | 106,880 | 0.8% |
| Deciphera Pharmaceuticals in(DCPHEUR)A | COM | 24344T101 | $1.5M | 69,700 | 0.8% |
| Mylan N VA | SHS EURO | N59465109 | $1.5M | 55,000 | 0.8% |
| Genomic Health Inc(GHDX)A | COM | 37244C101 | $1.5M | 23,866 | 0.8% |
| Illumina Inc(ILMN)A | COM | 452327109 | $1.5M | 5,148 | 0.8% |
| Qiagen NV(QGEN)A | SHS NEW | N72482123 | $1.9M | 55,300 | 1.0% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $2.1M | 165,000 | 1.1% |
| Abbott Labs(ABT)A | COM | 002824100 | $2.3M | 31,400 | 1.2% |
| Tesaro IncA | COM | 881569107 | $2.7M | 36,000 | 1.4% |
| Teligent Inc NewA | COM | 87960W104 | $3.1M | 2,247,476 | 1.7% |
| Arena Pharmaceuticals Inc(ARNAEUR)A | COM NEW | 040047607 | $3.2M | 81,371 | 1.7% |
| Ensign Group Inc(ENSG)A | COM | 29358P101 | $3.3M | 85,575 | 1.8% |
| Merck & Co Inc(MRK)A | COM | 58933Y105 | $3.5M | 45,800 | 1.9% |
| Argenx SE(ARGX)A | SPONSORED ADR | 04016X101 | $3.7M | 38,224 | 2.0% |
| Mylan N VCallA | SHS EURO | N59465109 | $4.3M | 158,600 | 2.4% |
| Sarepta Therapeutics Inc(SRPT)A | COM | 803607100 | $4.4M | 40,494 | 2.4% |